Corrinne Burns

Royal Pharmaceutical Society Correspondent

Corrinne Burns is Royal Pharmaceutical Society Correspondent at The Pharmaceutical Journal.

Legislation to speed up clinical trials comes into force

The law change enables researchers to simultaneously apply for ethics and regulatory approval for new clinical trials of investigational medicinal products.…

Pharmacy bodies call for urgent action on menopause care

A consensus statement endorsed by the Royal College of Pharmacy has warned that “there remains significant unmet need” regarding clear, evidence-based guidance and advice on menopause.…

Regulator sets actions for safeguarding in pharmacy weight management services

The General Pharmaceutical Council says pharmacy owners and superintendent pharmacists must document risk assessments for all aspects of weight management services.…

Fluoroquinolone prescribing in Wales reduced by over one-third over 12 months

According to the All-Wales Therapeutics and Toxicology Centre report, the most common fluoroquinolone prescribed in Wales was ciprofloxacin, followed by ofloxacin, as of March 2025.…

Paxlovid speeds COVID-19 recovery but does not reduce hospital admissions

Across two trials, more than 4,000 patients were randomised to receive usual care or Paxlovid (nirmatrelvir and ritonavir; Pfizer) within three or four days of symptom onset.…

SMRs cut prescribing of potentially inappropriate medicines by up to 40%

Researchers studying data from 635,698 patients discovered that non-steroidal anti-inflammatory drugs were the most commonly stopped prescription following a structured medication review.…

Royal College of Pharmacy appoints head of professional standards and patient safety

The College has also announced three more additions to its trustee board.…

Pharmacy regulator publishes AI position statement

The General Pharmaceutical Council said that pharmacy professionals should remember that they remain “personally accountable for their professional practice, even when AI is being used”.…

NICE recommends take-at-home tablet for chronic lymphocytic leukaemia

Pirtobrutinib has been approved for patients with recurrent chronic lymphocytic leukaemia — who have already been given a covalent BTK inhibitor (BTKi) — and for whom further covalent BTKi treatment is not suitable.…

Government is reviewing enforcement mechanisms on medicines shortages reporting

In its response to a House of Lords Public Services Committee report on medicines security, the Department of Health and Social Care said it hoped to improve compliance and timeliness of shortage reporting.…